COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 1468: Articles 14671-14680  | Next

Strategies to Mitigate COVID-19 Resurgence Assuming Immunity Waning: A Study for Karnataka, India
Athreya, S., Adiga, A., Lewis, B. L., Marathe, M., Rathod, N., Sundaresan, R., Swarup, S., Venkatramanan, S., Yasodharan, S.
10.1101/2021.05.26.21257836 — Posted: 2021-05-29
Assessing multiplex tiling PCR sequencing approaches for detecting genomic variants of SARS-CoV-2 in municipal wastewater
Lin, X., Glier, M., Kuchinski, K., Ross-Van Mierlo, T., McVea, D., Tyson, J. R., Prystajecky, N., Ziels, R. M.
10.1101/2021.05.26.21257861 — Posted: 2021-05-29
COVID-19 testing among children, parental preferences for testing venues and acceptability of school-based testing: a survey of US parents
Teasdale, C. A., Borrell, L. N., Shen, Y., Kimball, S., Rinke, M. L., Fleary, S. A., Nash, D.
10.1101/2021.05.27.21257932 — Posted: 2021-05-29
Modeling of the COVID-19 Cases in Gulf Cooperation Council (GCC) countries using ARIMA and MA-ARIMA models.
Eledum, H., Yagoub, R.
10.1101/2021.05.27.21257916 — Posted: 2021-05-29
Emergency department admissions during COVID-19: explainable machine learning to characterise data drift and detect emergent health risks
Duckworth, C., Chmiel, F. P., Burns, D. K., Zlatev, Z. D., White, N. M., Kiuber, M., Daniels, T. W. V., Boniface, M.
10.1101/2021.05.27.21257713 — Posted: 2021-05-29
Vaccine hesitancy and anti-vaccination attitudes during the start of COVID-19 vaccination program: a content analysis on Twitter data
Kücükali, H., Atac, O., Tokac, A. Z., Palteki, A. S., Hayran, O. E.
10.1101/2021.05.28.21257774 — Posted: 2021-05-29
Inferring SARS-CoV-2 variant within-host kinetics
Elie, B., Lecorche, E., Sofonea, M. T., Trombert, S., Foulogne, V., Guedj, J., Haim-Boukobza, S., Roquebert, B., Alizon, S.
10.1101/2021.05.26.21257835 — Posted: 2021-05-29
Development and external validation of a diagnostic multivariable prediction model for a prompt identification of cases at high risk for SARS-COV-2 infection among patients admitted to the emergency department
Ughi, N., ADINOLFI, A., CHEVALLARD, M., BELLOLI, L., SENATORE, M., TOSCANO, A., BELLONE, A., GIANNATTASIO, C., TARSIA, P., Puoti, M., SCAGLIONE, F., COLOMBO, F., BERTUZZI, M., BETTONI, G., FERRAZZI, D., MALOBERTI, A., DICUONZO, A., DEL GAUDIO, F., ROSSETTI, C., EPIS, O. M., Niguarda COVID group
10.1101/2021.05.26.21257834 — Posted: 2021-05-29
Antibody Response to CoronaVac Vaccine in Indonesian COVID-19 Survivor
Kemal, R. A., Sari, D. K., Paulina, A. J.
10.1101/2021.05.28.21254613 — Posted: 2021-05-29
Increased prevalence and clinical impact of hypocalcaemia in severe COVID-19 distinguishes it from other forms of infective pneumonia
Mehta, M., Ghani, H., Chua, F., Draper, A., Calmonson, S., Prabhakar, M., Shah, R., Navarra, A., Vaghela, T., Barlow, A., Vancheeswaran, R.
10.1101/2021.05.27.21257813 — Posted: 2021-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).